Llewelyn Linda (CIK 1780878) reported 8 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-03). Recent activity: Sell HCAT (8,519 shares), Sell HCAT (13,836 shares), Buy HCAT (191,500 shares), Buy HCAT (13,195 shares), Sell HCAT (4,471 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-03 | Health Catalyst, Inc. (HCAT) | Chief People Officer | Sell | 8,519 | $11,671 |
| 2026-03-05 | Health Catalyst, Inc. (HCAT) | Chief People Officer | Sell | 13,836 | $22,968 |
| 2026-02-27 | Health Catalyst, Inc. (HCAT) | Chief People Officer | Buy | 191,500 | $0 |
| 2026-02-27 | Health Catalyst, Inc. (HCAT) | Chief People Officer | Buy | 13,195 | $0 |
| 2026-02-27 | Health Catalyst, Inc. (HCAT) | Chief People Officer | Sell | 4,471 | $7,824 |
| 2025-12-03 | Health Catalyst, Inc. (HCAT) | Chief People Officer | Sell | 9,762 | $28,310 |
| 2025-09-04 | Health Catalyst, Inc. (HCAT) | Chief People Officer | Sell | 2,854 | $9,589 |
| 2025-06-03 | Health Catalyst, Inc. (HCAT) | Chief People Officer | Sell | 2,965 | $10,763 |
来源：SEC Form 4 申报文件 · 截至 2026-06-03